ASCEND BY NTHRYS
Research Abroad Products

Red Biotechnology Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Real-Time Multiplexed Immunoassay Platform for Biomarker Detection
A proprietary instrument and reagent system enabling simultaneous detection of 50+ disease biomarkers in a single blood sample within two hours. Establishes high-margin recurring revenue through reagent sales, instrument licensing, and managed laboratory services to hospital networks.
Red Biotech Diagnostic Product Development Click to view more details →
Smartphone-Integrated Lateral Flow Assay Reader with Data Management
A mobile-connected optical reader that captures and analyzes rapid diagnostic test results with cloud-based data aggregation and clinical decision support. Generates B2B2C revenue through bulk device sales, cloud subscription tiers, and data licensing for epidemiological research.
Red Biotech Diagnostic Product Development Click to view more details →
Next-Generation Sequencing Data Interpretation Pipeline for Clinical Use
A bioinformatics platform that processes NGS data to identify disease-causing variants and delivers clinician-friendly reports with actionable recommendations. Monetizes through software licensing, per-sample analysis fees, and white-label partnerships with genomic testing companies and hospitals.
Red Biotech Diagnostic Product Development Click to view more details →
Non-Invasive Prenatal Testing Platform Using Cell-Free DNA
A commercial diagnostic service offering NIPT screening for chromosomal abnormalities with AI-enhanced risk prediction and genetic counseling integration. Captures revenue from per-test fees, OB/GYN practice partnerships, and insurance reimbursement while expanding into carrier screening markets.
Red Biotech Diagnostic Product Development Click to view more details →
Microbiome Profiling and Dysbiosis Assessment Diagnostic Service
A metagenomic sequencing service that analyzes patient microbiome composition and delivers clinical reports linking dysbiosis to disease conditions and treatment recommendations. Generates revenue through test subscriptions, gastroenterology practice partnerships, and probiotic company collaborations.
Red Biotech Diagnostic Product Development Click to view more details →
Automated Molecular Diagnostics Laboratory Information System Platform
An integrated software suite managing sample tracking, instrument connectivity, result interpretation, and quality assurance for high-throughput diagnostic labs. Delivers SaaS revenue through monthly subscriptions scaled by sample volume plus implementation and training services for laboratory automation.
Red Biotech Diagnostic Product Development Click to view more details →
CAR-T Cell Manufacturing Automation Platform
A SaaS-integrated manufacturing platform automates CAR-T cell production workflows, from patient sample processing through cryopreservation, reducing manual labor and production timelines. This delivers significant cost savings per therapeutic unit and enables contract manufacturers to scale patient throughput by 3-5x, creating recurring licensing and per-batch revenue models.
Red Biotech Gene & Cell Therapy Development Click to view more details →
Gene Therapy Vector Optimization and Scale-up Service
A specialized CDMO service optimizes viral and non-viral gene therapy vectors for manufacturability while maintaining potency, then scales production from grams to clinical-grade quantities. Revenue flows from upfront optimization consulting fees, milestone-based scale-up contracts, and ongoing manufacturing capacity agreements with biotech developers.
Red Biotech Gene & Cell Therapy Development Click to view more details →
Real-time Cell Viability and Potency Monitoring Software
Proprietary software integrates with bioreactor sensors and automated microscopy to provide continuous, non-destructive monitoring of cell health, transduction efficiency, and therapeutic potency during manufacturing. This SaaS offering reduces batch failures, speeds time-to-release decisions, and commands subscription pricing plus data analytics licensing to therapeutics manufacturers and CMOs.
Red Biotech Gene & Cell Therapy Development Click to view more details →
iPSC-to-Therapeutic Cell Line Engineering Platform
A cloud-based bioinformatics and automation platform designs optimized iPSC-derived cell lines with integrated safety switches, enhanced functionality, and manufacturing robustness using AI-guided genome editing. The platform generates revenue through per-program development fees, cell line licensing agreements, and ongoing optimization services for pharma and regenerative medicine companies.
Red Biotech Gene & Cell Therapy Development Click to view more details →
Allogeneic Cell Therapy Immunogenicity Prediction Tool
A machine learning tool predicts major histocompatibility complex (MHC) mismatch immunogenicity and suggests HLA-matching or immune-evasion strategies before manufacturing scale-up of off-the-shelf cell therapies. Developers gain actionable insights reducing clinical failure risk, enabling B2B SaaS licensing, preclinical data packages for pharma partnerships, and manufacturing optimization consulting.
Red Biotech Gene & Cell Therapy Development Click to view more details →
Lentiviral Vector Production Closed-system Bioreactor
A proprietary bioreactor system automates lentiviral vector manufacturing in a fully closed, scalable format with integrated purification and formulation, maintaining GMP compliance and product consistency. The hardware business model combines equipment sales, consumable recurring revenue (cell culture media, filtration cartridges), and service contracts supporting clinical and commercial-scale gene therapy programs.
Red Biotech Gene & Cell Therapy Development Click to view more details →